The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates

Table 1

Comparison of clinical and demographic variables in CS and PD participants.

	CS (𝑛=32)	PD (𝑛=28)	Significance
Age	56.3 (9.2)	66.5 (11.9)	𝑃<.0001^∗∗∗
Education	15.3 (2.7)	13.9 (3.0)	ns
MMSE	28.3 (1.5)	26.6 (1.7)	𝑃<.0001^∗∗∗
DASS—Anxiety	2.12 (2.4)	5.32 (4.1)	𝑃<.0001^∗∗∗
DASS—Depression	3.94 (4.7)	4.32 (4.3)	ns
Stroop 3 Interference	46.8 (29.8)	51.3 (29.8)	ns
Disease Duration	N/A	9.01 (4.96)	N/A
H and Y Stage^a	N/A	3 (2–3)	N/A
UPDRS total	N/A	25.3 (13.1)	N/A
LDE	N/A	628.9 (330.8)	N/A

Notes: ^∗∗∗𝑃<.0001; ns: not significant; N/A: not applicable; CS: control; PD: Parkinson’s disease; MMSE: mini-mental state exam; DASS: Depression Anxiety Stress Scales; H & Y Stage: Hoehn & Yahr Stage; UPDRS: Unified Parkinson’s Disease Rating Scale; LDE: Levodopa Dosage Equivalent.
^aMedian (range) is reported.